[go: up one dir, main page]

NO990261L - Tramadol multiple enhetsformuleringer - Google Patents

Tramadol multiple enhetsformuleringer

Info

Publication number
NO990261L
NO990261L NO990261A NO990261A NO990261L NO 990261 L NO990261 L NO 990261L NO 990261 A NO990261 A NO 990261A NO 990261 A NO990261 A NO 990261A NO 990261 L NO990261 L NO 990261L
Authority
NO
Norway
Prior art keywords
multiple unit
unit formulations
tramadol
tramadol multiple
formulations
Prior art date
Application number
NO990261A
Other languages
English (en)
Other versions
NO324207B1 (no
NO990261D0 (no
Inventor
Helmut Momberger
Marc Raber
Dieter Kuhn
Wolfgang Schmid
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO990261D0 publication Critical patent/NO990261D0/no
Publication of NO990261L publication Critical patent/NO990261L/no
Publication of NO324207B1 publication Critical patent/NO324207B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
NO19990261A 1996-07-25 1999-01-21 Farmasoytiske multiple enhetsformuleringer med tramadol, samt fremgangsmate til fremstilling derav. NO324207B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19630035A DE19630035A1 (de) 1996-07-25 1996-07-25 Tramadol Multiple Unit Formulierungen
PCT/EP1997/003934 WO1998004249A2 (de) 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen

Publications (3)

Publication Number Publication Date
NO990261D0 NO990261D0 (no) 1999-01-21
NO990261L true NO990261L (no) 1999-01-21
NO324207B1 NO324207B1 (no) 2007-09-10

Family

ID=7800815

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990261A NO324207B1 (no) 1996-07-25 1999-01-21 Farmasoytiske multiple enhetsformuleringer med tramadol, samt fremgangsmate til fremstilling derav.

Country Status (28)

Country Link
US (2) US5955104A (no)
EP (1) EP0917463B1 (no)
JP (1) JP3631762B2 (no)
KR (1) KR100474793B1 (no)
CN (1) CN1111402C (no)
AR (1) AR008002A1 (no)
AT (1) ATE213408T1 (no)
AU (1) AU737121B2 (no)
BG (1) BG63708B1 (no)
BR (1) BR9710761A (no)
CA (1) CA2211284C (no)
CZ (1) CZ296964B6 (no)
DE (2) DE19630035A1 (no)
DK (1) DK0917463T3 (no)
EE (1) EE03742B1 (no)
ES (1) ES2171268T3 (no)
HU (1) HU227971B1 (no)
IL (1) IL127915A (no)
NO (1) NO324207B1 (no)
NZ (1) NZ333822A (no)
PL (1) PL188834B1 (no)
PT (1) PT917463E (no)
RU (1) RU2201223C2 (no)
SK (1) SK285300B6 (no)
TW (1) TW495363B (no)
UA (1) UA52679C2 (no)
WO (1) WO1998004249A2 (no)
ZA (1) ZA975408B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
US6197347B1 (en) * 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
DE19901686A1 (de) 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
DE19901687B4 (de) * 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
CZ2002671A3 (cs) * 1999-08-31 2002-06-12 Grünenthal GmbH Léková forma se zpoľděným účinkem obsahující tramadolsacharinát
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN102716101A (zh) 1999-10-29 2012-10-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6620431B1 (en) 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
JP5014554B2 (ja) * 2000-06-14 2012-08-29 ジェイカムアグリ株式会社 被覆生物活性粒状物の製造方法
WO2002003914A2 (en) * 2000-07-06 2002-01-17 Delsys Pharmaceutical Corporation Improved thyroid hormone formulations
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
RU2174836C1 (ru) * 2000-12-15 2001-10-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая анальгезирующим действием
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
WO2003009805A2 (en) * 2001-07-23 2003-02-06 Brigham And Women's Hospital, Inc. Analgesic methods using endothelin receptor ligands
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
NZ535455A (en) * 2002-02-21 2009-08-28 Biovail Lab Int Srl Controlled release dosage forms
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
DK1894562T3 (da) * 2002-08-15 2011-03-28 Euro Celtique Sa Farmaceutiske sammensætninger omfattende en opioidantagonist
DE50207738D1 (de) * 2002-11-27 2006-09-14 Oramon Arzneimittel Gmbh & Co Verfahren zur Herstellung von Pellets, enthaltend ein tri- oder tetracyclisches Antidepressivum sowie diese Pellets enthaltende pharmazeutische Zubereitungen
US20060153915A1 (en) * 2003-01-23 2006-07-13 Amorepacific Corporation Sustained-release preparations and method for producing the same
RU2223757C1 (ru) * 2003-03-04 2004-02-20 Закрытое акционерное общество "Брынцалов-А" Препарат, обладающий анальгезирующим действием
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20050053669A1 (en) * 2003-09-05 2005-03-10 Boehringer Ingelheim International Gmbh Administration form for the oral application of poorly soluble acidic and amphorteric drugs
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
EP1677768A4 (en) * 2003-10-03 2011-06-29 Elite Lab Inc PROLONGED RELEASE OPIOID FORMULATIONS AND METHOD OF USING THE FORMULATIONS
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
WO2006009403A1 (en) * 2004-07-22 2006-01-26 Amorepacific Corporation Sustained-release preparations containing topiramate and the producing method thereof
US9326959B2 (en) 2004-09-01 2016-05-03 Purdue Pharma, L.P. Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
WO2007016948A1 (de) * 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Orales präparat mit kontrollierter freisetzung
CA2628031C (en) * 2005-11-10 2013-03-05 Circ Pharma Research And Development Limited Once-daily administration of central nervous system drugs
US20070185145A1 (en) * 2006-02-03 2007-08-09 Royds Robert B Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
US20070264335A1 (en) * 2006-05-09 2007-11-15 Sherman Bernard C Modified release tablets comprising tramadol
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
US10888521B2 (en) * 2007-03-02 2021-01-12 Farnam Companies, Inc. Sustained release compositions using wax-like materials
CN105534936B (zh) * 2007-08-13 2020-07-31 Ohemo 生命科学股份有限公司 抗滥用药物、使用方法和制备方法
CN101095666B (zh) * 2007-08-14 2010-10-06 石药集团欧意药业有限公司 一种盐酸曲马多缓释片剂及其制备方法
CZ300468B6 (cs) * 2007-09-20 2009-05-27 Zentiva, A. S Léková forma obsahující tramadol s kontrolovaným uvolnováním po dobu 24 hodin a zpusob její prípravy
US20100285119A1 (en) * 2008-01-11 2010-11-11 Jubilant Organosys Ltd. Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
CA2736119C (en) * 2008-09-04 2016-08-23 Farnam Companies, Inc. Chewable sustained release formulations
FR2938431B1 (fr) * 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
DK2358360T3 (en) 2008-11-18 2016-12-12 Ucb Biopharma Sprl EXTENDED release formulations comprising one 2-OXO-1 PYRROLIDIN DERIVATIVE
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
WO2012003968A1 (en) 2010-07-06 2012-01-12 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
PL2872121T3 (pl) 2012-07-12 2019-02-28 SpecGx LLC Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
US20140275149A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
IT201800011125A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide comprendenti matrici monolitiche complesse per la somministrazione cronotropica di medicamenti nel tratto gastroenterico

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
SG80535A1 (en) * 1991-09-06 2001-05-22 Mcneilab Inc Composition comprising a tramadol material and acetaminophen and its use
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
DE4428444A1 (de) * 1994-08-11 1996-02-15 Dresden Arzneimittel Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen

Also Published As

Publication number Publication date
AU737121B2 (en) 2001-08-09
IL127915A (en) 2001-08-08
KR20000029530A (ko) 2000-05-25
PL331387A1 (en) 1999-07-05
SK9899A3 (en) 1999-09-10
KR100474793B1 (ko) 2005-03-08
PT917463E (pt) 2002-07-31
NO324207B1 (no) 2007-09-10
HK1020876A1 (en) 2000-05-26
HUP9903053A3 (en) 2000-02-28
IL127915A0 (en) 1999-11-30
CN1226824A (zh) 1999-08-25
CZ18599A3 (cs) 1999-04-14
DK0917463T3 (da) 2002-06-10
UA52679C2 (uk) 2003-01-15
EP0917463A2 (de) 1999-05-26
SK285300B6 (sk) 2006-10-05
AR008002A1 (es) 1999-11-24
CZ296964B6 (cs) 2006-08-16
CN1111402C (zh) 2003-06-18
EP0917463B1 (de) 2002-02-20
US6436438B1 (en) 2002-08-20
TW495363B (en) 2002-07-21
AU3849197A (en) 1998-02-20
HUP9903053A2 (hu) 2000-01-28
BG103158A (en) 1999-08-31
NO990261D0 (no) 1999-01-21
DE19630035A1 (de) 1998-01-29
BG63708B1 (bg) 2002-10-31
ES2171268T3 (es) 2002-09-01
EE03742B1 (et) 2002-06-17
DE59706441D1 (de) 2002-03-28
CA2211284A1 (en) 1998-01-25
HU227971B1 (en) 2012-07-30
PL188834B1 (pl) 2005-04-29
CA2211284C (en) 2001-10-23
NZ333822A (en) 1999-11-29
BR9710761A (pt) 1999-08-17
ATE213408T1 (de) 2002-03-15
WO1998004249A2 (de) 1998-02-05
RU2201223C2 (ru) 2003-03-27
EE9900031A (et) 1999-08-16
JP3631762B2 (ja) 2005-03-23
WO1998004249A3 (de) 1998-04-30
JP2000515871A (ja) 2000-11-28
US5955104A (en) 1999-09-21
ZA975408B (en) 1998-01-05

Similar Documents

Publication Publication Date Title
ATE213408T1 (de) Tramadol multiple unit formulierungen
MA24473A1 (fr) Formulations
DE69714227D1 (de) Abseilgerät
EE9700138A (et) Aerosoolravimvormid
DK0901753T3 (da) Herbicid sammensætning
ITMI940559A0 (it) Innesto multiplo
BR9708893A (pt) Ferniluracilas substituidas
NO991430D0 (no) Insektfordrivende formuleringer
BR9603495A (pt) Central elétrica
DE69726475D1 (de) Monitor
FI963434A0 (fi) Kraftoeverfoeringsanordning till rotationskolvmotor
KR950022504U (ko) 구두
KR980000677U (ko) 다용도 좌욕기
FI946210A0 (fi) Paula
FI960505A0 (fi) Äes Äes
SE9404469D0 (sv) Aerosol formulations
FI3003U1 (fi) Kuormapankka
FIU960242U0 (fi) Kaluste
KR970064203U (ko) 푸셔 유니트
KR960000449U (ko) 구두딱기
KR960006848U (ko) 신발
KR960019720U (ko) 구두
KR960019721U (ko) 신발
KR960013126U (ko) 신발
KR960013125U (ko) 신발

Legal Events

Date Code Title Description
MK1K Patent expired